🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Sjögren's syndrome is a condition in which the immune system attacks the bo...
Status
Not Yet Recruiting
Location
Instituto de Oftalmología Conde de Valenciana
Start Date
2026-12
Trial ID
NCT07671222
Treatments Being Tested
To investigate the safety and efficacy of DE-112 in lowering intraocular pr...
Status
Completed
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01279083
Treatments Being Tested
This is a Phase 3, randomized, placebo-controlled, double masked, parallel ...
Status
Completed
Location
American Genomics Site 2
Start Date
2021-03-30
Trial ID
NCT04829344
The objective of this study was to compare the safety, efficacy, and tolera...
Status
Completed
Location
CYS-002 Investigational Site
Start Date
2016-01
Trial ID
NCT02617667
Treatments Being Tested
This is a Phase 2, prospective, randomized, double-masked, vehicle controll...
Status
Completed
Location
Doheny Eye Center
Start Date
2016-03
Trial ID
NCT02693119
Treatments Being Tested
The objectives of this study are: * To evaluate the efficacy of Nyxol (phe...
Status
Completed
Location
Kannar Eye Care
Start Date
2019-08-13
Trial ID
NCT04024891
The objective of this study was to compare the safety and efficacy of 0.25%...
Status
Completed
Location
Cornea and Cataract Consultants of Arizona
Start Date
2019-03-10
Trial ID
NCT03846453
Treatments Being Tested
The primary objective of this study is to assess the efficacy and safety of...
Status
Completed
Location
Auven Therapeutics
Start Date
2014-12
Trial ID
NCT02329743
Treatments Being Tested
To evaluate the efficacy and safety of PR013 topical ophthalmic drops (0.04...
Status
Completed
Location
Principal Investigator
Start Date
2017-12-10
Trial ID
NCT03368339
Treatments Being Tested
Study to evaluate the safety and tolerability of MC-1101, a potential topic...
Status
Completed
Location
Sall Eye Center
Start Date
2013-09
Trial ID
NCT01922128
Treatments Being Tested